NCT02497612 - To Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of a Single Dose Regimen of Ferroquine and Artefenomel in Adults and Children With Uncomplicated Plasmodium Falciparum Malaria | Biotech Hunter

Enrollment

377

Participants

Timeline

Start Date

July 25, 2015

Primary Completion Date

September 23, 2019

Study Completion Date

September 23, 2019

Conditions

Plasmodium Falciparum Infection

Interventions

DRUG

Ferroquine SSR97193

Pharmaceutical form:Capsules Route of administration: oral

DRUG

Artefenomel

Pharmaceutical form:Granules for suspension Route of administration: oral

OTHER

Placebo

Capsules. Placebo capsules were used to keep the same number of capsules in each weight band while keeping the ferroquine dose blinded. No participant received placebo only.

Trial Locations (12)

Unknown

Investigational Site Number 204001, Cotonou

Investigational Site Number 854002, Comoé

Investigational Site Number 854003, Niangoloko

Investigational Site Number 854001, Ouagadougou

Investigational Site Number 266002, Lambaréné

Investigational Site Number 266001, Libreville

Investigational Site Number 404003, Kisumu

Investigational Site Number 404002, Siaya

Investigational Site Number 508001, Chokwé

Investigational Site Number 800002, Tororo

Investigational Site Number 704003, Bình Phước

Investigational Site Number 704004, Pleiku